<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Paltzer WG</submitter><funding>American Heart Association</funding><funding>NHLBI NIH HHS</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>U.S. Department of Defense</funding><funding>Israel National Road Safety Authority</funding><funding>National Institutes of Health</funding><funding>National Institute of General Medical Sciences</funding><funding>NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>15-25</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10922357</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>187</volume><pubmed_abstract>The metabolic switch from glycolysis to fatty acid oxidation in postnatal cardiomyocytes contributes to the loss of the cardiac regenerative potential of the mammalian heart. However, the mechanisms that regulate this metabolic switch remain unclear. The protein kinase complex mechanistic target of rapamycin complex 1 (mTORC1) is a central signaling hub that regulates cellular metabolism and protein synthesis, yet its role during mammalian heart regeneration and postnatal metabolic maturation is undefined. Here, we use immunoblotting, rapamycin treatment, myocardial infarction, and global proteomics to define the role of mTORC1 in postnatal heart development and regeneration. Our results demonstrate that the activity of mTORC1 is dynamically regulated between the regenerating and the non-regenerating hearts. Acute inhibition of mTORC1 by rapamycin or everolimus reduces cardiomyocyte proliferation and inhibits neonatal heart regeneration following injury. Our quantitative proteomic analysis demonstrates that transient inhibition of mTORC1 during neonatal heart injury did not reduce protein synthesis, but rather shifts the cardiac proteome of the neonatal injured heart from glycolysis towards fatty acid oxidation. This indicates that mTORC1 inhibition following injury accelerates the postnatal metabolic switch, which promotes metabolic maturation and impedes cardiomyocyte proliferation and heart regeneration. Taken together, our results define an important role for mTORC1 in regulating postnatal cardiac metabolism and may represent a novel target to modulate cardiac metabolism and promote heart regeneration.</pubmed_abstract><journal>Journal of molecular and cellular cardiology</journal><pubmed_title>mTORC1 regulates the metabolic switch of postnatal cardiomyocytes during regeneration.</pubmed_title><pmcid>PMC10922357</pmcid><funding_grant_id>R01 HL109810</funding_grant_id><funding_grant_id>R01 HL166256</funding_grant_id><funding_grant_id>T32 HL007936</funding_grant_id><funding_grant_id>W81XWH2210094</funding_grant_id><funding_grant_id>S10 OD025040</funding_grant_id><funding_grant_id>T32 GM007133</funding_grant_id><funding_grant_id>S10 OD018475</funding_grant_id><funding_grant_id>R56 HL155617</funding_grant_id><funding_grant_id>19CDA34660169</funding_grant_id><funding_grant_id>F31 HL167328</funding_grant_id><funding_grant_id>T32 GM008688</funding_grant_id><funding_grant_id>R01 HL096971</funding_grant_id><pubmed_authors>Flynn CGK</pubmed_authors><pubmed_authors>Nahlawi R</pubmed_authors><pubmed_authors>Paltzer WG</pubmed_authors><pubmed_authors>Hubert KA</pubmed_authors><pubmed_authors>Ge Y</pubmed_authors><pubmed_authors>Aballo TJ</pubmed_authors><pubmed_authors>Nuttall DJ</pubmed_authors><pubmed_authors>Mahmoud AI</pubmed_authors><pubmed_authors>Wanless KN</pubmed_authors><pubmed_authors>Bae J</pubmed_authors><pubmed_authors>Perry C</pubmed_authors></additional><is_claimable>false</is_claimable><name>mTORC1 regulates the metabolic switch of postnatal cardiomyocytes during regeneration.</name><description>The metabolic switch from glycolysis to fatty acid oxidation in postnatal cardiomyocytes contributes to the loss of the cardiac regenerative potential of the mammalian heart. However, the mechanisms that regulate this metabolic switch remain unclear. The protein kinase complex mechanistic target of rapamycin complex 1 (mTORC1) is a central signaling hub that regulates cellular metabolism and protein synthesis, yet its role during mammalian heart regeneration and postnatal metabolic maturation is undefined. Here, we use immunoblotting, rapamycin treatment, myocardial infarction, and global proteomics to define the role of mTORC1 in postnatal heart development and regeneration. Our results demonstrate that the activity of mTORC1 is dynamically regulated between the regenerating and the non-regenerating hearts. Acute inhibition of mTORC1 by rapamycin or everolimus reduces cardiomyocyte proliferation and inhibits neonatal heart regeneration following injury. Our quantitative proteomic analysis demonstrates that transient inhibition of mTORC1 during neonatal heart injury did not reduce protein synthesis, but rather shifts the cardiac proteome of the neonatal injured heart from glycolysis towards fatty acid oxidation. This indicates that mTORC1 inhibition following injury accelerates the postnatal metabolic switch, which promotes metabolic maturation and impedes cardiomyocyte proliferation and heart regeneration. Taken together, our results define an important role for mTORC1 in regulating postnatal cardiac metabolism and may represent a novel target to modulate cardiac metabolism and promote heart regeneration.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2026-06-01T05:46:28.264Z</modification><creation>2025-04-05T19:19:39.273Z</creation></dates><accession>S-EPMC10922357</accession><cross_references><pubmed>38141532</pubmed><doi>10.1016/j.yjmcc.2023.12.004</doi></cross_references></HashMap>